RT Journal Article ID 0e25b3eb2d50474b A1 Rai, Mahendra K. A1 Gaikwad, Swapnil A1 Nagaonkar, Dipali A1 dos Santos, Carolina Alves T1 Current Advances in the Antimicrobial Potential of Species of Genus Ganoderma (Higher Basidiomycetes) against Human Pathogenic Microorganisms (Review) JF International Journal of Medicinal Mushrooms JO IJM YR 2015 FD 2016-01-07 VO 17 IS 10 SP 921 OP 932 K1 medicinal mushrooms K1 antimicrobial bioactive compounds K1 Ganoderma spp. K1 metal nanoparticles AB Ganoderma spp. are very important therapeutic mushrooms and have been used traditionally for 4000 years in the treatment of various human disorders. Different species of Ganoderma possess bioactive compounds, which have already demonstrated antiviral, antibacterial, and antifungal activities. Various bioactive compounds such as triterpenoids, colossolactones, and polysaccharides, which are responsible for the antimicrobial potential of the genus, are discussed here in detail. Some Ganoderma spp. have been reported to be potential agents for the synthesis of metal nanoparticles. These nanoparticles have demonstrated antimicrobial activity and also are reviewed herein. The main aim of this review is to discuss the possible use of Ganoderma extracts and their active principles in antimicrobial therapy. PB Begell House LK https://www.dl.begellhouse.com/journals/708ae68d64b17c52,2fb21a9c4fd053ea,0e25b3eb2d50474b.html